$922 Million is the total value of VR Adviser, LLC's 28 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 44.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ALT | Sell | ALTIMMUNE INC | $49,455,000 | -2.6% | 3,500,000 | -22.2% | 5.36% | -28.1% |
KROS | Sell | KEROS THERAPEUTICS INC | $22,915,000 | -51.7% | 372,306 | -44.6% | 2.49% | -64.3% |
SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $13,232,000 | -46.7% | 591,782 | -46.9% | 1.44% | -60.6% |
MTCR | Sell | METACRINE INC | $4,216,000 | -22.7% | 680,000 | -2.0% | 0.46% | -43.0% |
SBTX | Sell | SILVERBACK THERAPEUTICS INC | $3,709,000 | -46.6% | 85,000 | -43.3% | 0.40% | -60.7% |
BCAB | Exit | BIOATLA INC | $0 | – | -100,000 | -100.0% | -0.50% | – |
FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -245,122 | -100.0% | -0.61% | – |
GRTX | Exit | GALERA THERAPEUTICS INC | $0 | – | -917,860 | -100.0% | -1.38% | – |
SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -1,442,895 | -100.0% | -1.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
AFFIMED N V | 8 | Q3 2023 | 1.1% |
INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR/A | 2023-05-15 |
13F-HR/A | 2023-05-15 |
13F-HR/A | 2023-05-15 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.